Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jul;89(7):796-8.
doi: 10.1136/bjo.2004.061895.

Onchocerciasis: a potential risk factor for glaucoma

Affiliations

Onchocerciasis: a potential risk factor for glaucoma

P R Egbert et al. Br J Ophthalmol. 2005 Jul.

Abstract

Background: Onchocerciasis is a microfilarial disease that causes ocular disease and blindness. Previous evidence of an association between onchocerciasis and glaucoma has been mixed. This study aims to further investigate the association between onchocerciasis and glaucoma.

Methods: All subjects were patients at the Bishop John Ackon Christian Eye Centre in Ghana, west Africa, undergoing either trabeculectomy for advanced glaucoma or extracapsular extraction for cataracts, who also had a skin snip biopsy for onchocerciasis. A cross sectional case-control study was performed to assess the difference in onchocerciasis prevalence between the two study groups.

Results: The prevalence of onchocerciasis was 10.6% in those with glaucoma compared with 2.6% in those with cataracts (OR, 4.45 (95% CI 1.48 to 13.43)). The mean age in the glaucoma group was significantly younger than in the cataract group (59 and 65, respectively). The groups were not significantly different with respect to sex or region of residence. In models adjusted for age, region, and sex, subjects with glaucoma had over three times the odds of testing positive for onchocerciasis (OR, 3.50 (95% CI 1.10 to 11.18)).

Conclusions: This study has shown a positive association between subclinical onchocerciasis and glaucoma. This finding emphasises the importance of eradication of onchocerciasis from west Africa.

PubMed Disclaimer

Comment in

  • The order is rapidly fadin'.
    Chidambaram JD, Lietman TM. Chidambaram JD, et al. Br J Ophthalmol. 2005 Jul;89(7):789-90. doi: 10.1136/bjo.2005.065847. Br J Ophthalmol. 2005. PMID: 15965148 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. World Health Organization. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control 1995:1–104. - PubMed
    1. Newland HS, White AT, Greene BM, et al. Ocular manifestations of onchocerciasis in a rain forest area of west Africa. Br J Ophthalmol 1991;75:163–9. - PMC - PubMed
    1. Burnham G. Onchocerciasis. Lancet 1998;351:1341–6. - PubMed
    1. Dadzie KY, Awadzi K, Bird AC, et al. Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis. Trop Med Parasitol 1989;40:355–60. - PubMed
    1. Dadzie KY, Remme J, De Sole G. Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus. Trans R Soc Trop Med Hyg 1991;85:267–71. - PubMed